OncoMed Pharmaceuticals IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  2015 IPOs
  2014 IPOs
  2013 IPOs
  2012 IPOs
  2011 IPOs
  2010 IPOs
  Last 10 IPO's & Quotes
  Sample IPO
  Rating Scale
  IPO Primer
  Current Week
  Track Record
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  2011 Secondaries
  2010 Secondaries
  Secondaries Primer
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Site Map
  A Touch of Humor

For IPO Boutique's "scale of 1 to 5" BUY rating on OncoMed Pharmaceuticals, and our comprehensive analysis, click the "Buy Market Research" link.
Price Range
Issue Price
Trade Date
OncoMed PharmaceuticalsOMED
[ Nasdaq ]
Priced at $17.00 $17.00 $17.004.8 million7/18/2013
Jefferies, Leerink Swann
Piper Jaffray, BMO Capital Markets

Filed 2012-05-11

OncoMed Pharmaceuticals Historical Chart - Click chart for current quote

About OncoMed Pharmaceuticals (adapted from OncoMed Pharmaceuticals prospectus):
OncoMed is a clinical development-stage biopharmaceutical company focused on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells, or CSCs. Their approach has been to target CSCs, which are the subpopulation of cells in a tumor responsible for driving growth and metastasis of the tumor. Common cancer drugs target bulk tumor cells but have limited impact on CSCs. OncoMed's product candidates target CSCs by blocking self-renewal and driving differentiation of CSCs toward a non-tumorigenic state, and also impact bulk tumor cells.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as "OMED" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription

© 2005 - 2015 IPO Boutique. All Rights Reserved